OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an important source of recurrent cardiovascular events. The presence of high-risk plaques (HRP), identified by optical coherence tomography (OCT) in lesions with negative FFR, has been associated with worse long-term clinical outcomes.

The aim of this prospective, observational, multicenter study was to evaluate the association between HRP and cardiovascular events after MI during a 5-year follow-up period.

A total of 438 patients with recent MI (STEMI or NSTEMI) were included. OCT was performed in all intermediate non-culprit lesions (30–90% visual stenosis) with an FFR >0.80. HRP was defined according to OCT criteria as the presence of at least two of the following three features: lipid arc ≥90°, minimum fibrous cap thickness <65 µm, and plaque rupture or thrombus.

The primary endpoint (PEP) was patient-level major adverse cardiovascular events (MACE), defined as cardiac death, non-fatal MI, or unplanned revascularization at 5 years.

The prevalence of HRP was 34% (143 out of 420 analyzed patients). Regarding outcomes, the MACE rate was significantly higher in the HRP group compared with patients without HRP (18.9% vs. 10.8%; HR 1.87; 95% CI: 1.11–3.14; p=0.017).

When analyzing the individual components of the primary endpoint, the risk of non-fatal MI was four times higher in patients with HRP (HR 4.07; p=0.013), while the need for unplanned revascularization was nearly doubled (HR 1.97; p=0.027).

Read also: Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

The risk associated with HRP was mainly concentrated within the first two years of follow-up (HR 2.67; p=0.006). Between years 2 and 5, the difference was no longer statistically significant (HR 1.25; p=0.581). Among the OCT findings, non-culprit plaque rupture showed the strongest association with adverse outcomes (HR 3.20 for MACE; p<0.001).

OCT-Detected High-Risk Plaques Increase MACE Risk After Myocardial Infarction Despite Negative FFR

High-risk non-culprit plaques, even in the absence of significant flow limitation, are associated with an increased risk of long-term adverse clinical events after myocardial infarction. OCT identification of these plaques allows the detection of a higher-risk population that may benefit from more intensive therapeutic strategies.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

Shortened DAPT Regimens According to the PRECISE-HBR Score

The optimal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention depends on balancing the prevention of ischemic events against the risk of...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Shortened DAPT Regimens According to the PRECISE-HBR Score

The optimal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention depends on balancing the prevention of ischemic events against the risk of...

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...